Green Cross Holdings Preference Shares (005257) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Green Cross Holdings Preference Shares (005257) has a cash flow conversion efficiency ratio of -0.043x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-73.64 Billion ≈ $-49.91 Million USD) by net assets (₩1.72 Trillion ≈ $1.17 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 005257 stock market capitalisation for the company's overall valuation and market capitalisation.
Green Cross Holdings Preference Shares - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Green Cross Holdings Preference Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Green Cross Holdings Preference Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross Holdings Preference Shares ranked by their cash flow conversion efficiency. Explore cash flow quality index of Green Cross Holdings Preference Shares to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Puma VCT 13 PLC
LSE:PU13
|
-0.005x |
|
aovo Touristik AG
MU:A8N
|
0.246x |
|
Nocera Inc
NASDAQ:NCRA
|
-0.164x |
|
OLB Group Inc
NASDAQ:OLB
|
-0.165x |
|
Victorian Plumbing Group PLC
LSE:VIC
|
0.238x |
|
MacDonald Mines Exploration Ltd
V:BMK
|
-0.004x |
|
8I Holdings Ltd
AU:8IH
|
-0.057x |
|
Metalore Resources Ltd
V:MET
|
0.024x |
Annual Cash Flow Conversion Efficiency for Green Cross Holdings Preference Shares (2013–2025)
The table below shows the annual cash flow conversion efficiency of Green Cross Holdings Preference Shares from 2013 to 2025. View Green Cross Holdings Preference Shares stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩1.76 Trillion ≈ $1.20 Billion |
₩24.30 Billion ≈ $16.47 Million |
0.014x | +128.37% |
| 2024-12-31 | ₩1.85 Trillion ≈ $1.26 Billion |
₩-89.95 Billion ≈ $-60.96 Million |
-0.049x | -130.42% |
| 2023-12-31 | ₩1.88 Trillion ≈ $1.28 Billion |
₩-39.65 Billion ≈ $-26.87 Million |
-0.021x | -142.67% |
| 2022-12-31 | ₩1.97 Trillion ≈ $1.33 Billion |
₩97.16 Billion ≈ $65.84 Million |
0.049x | -9.05% |
| 2021-12-31 | ₩1.91 Trillion ≈ $1.29 Billion |
₩103.77 Billion ≈ $70.32 Million |
0.054x | +154.07% |
| 2020-12-31 | ₩1.67 Trillion ≈ $1.13 Billion |
₩35.77 Billion ≈ $24.24 Million |
0.021x | +320.95% |
| 2019-12-31 | ₩1.51 Trillion ≈ $1.02 Billion |
₩7.65 Billion ≈ $5.18 Million |
0.005x | -80.40% |
| 2018-12-31 | ₩1.45 Trillion ≈ $984.76 Million |
₩37.64 Billion ≈ $25.51 Million |
0.026x | -74.19% |
| 2017-12-31 | ₩1.44 Trillion ≈ $975.64 Million |
₩144.48 Billion ≈ $97.91 Million |
0.100x | +17256.99% |
| 2016-12-31 | ₩1.38 Trillion ≈ $933.18 Million |
₩-805.47 Million ≈ $-545.86K |
-0.001x | -110.87% |
| 2015-12-31 | ₩1.31 Trillion ≈ $885.99 Million |
₩7.04 Billion ≈ $4.77 Million |
0.005x | -88.35% |
| 2014-12-31 | ₩1.18 Trillion ≈ $800.39 Million |
₩54.54 Billion ≈ $36.96 Million |
0.046x | +189.06% |
| 2013-12-31 | ₩1.10 Trillion ≈ $745.23 Million |
₩17.57 Billion ≈ $11.91 Million |
0.016x | -- |
About Green Cross Holdings Preference Shares
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and… Read more